Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly

Autor: Guojin Li, Hongdou Jia, R. Bucktrout, Rankun Zuo, Xin Shu, Xinwei Li, Juan J. Loor, Xiaobing Li, Zhe Wang, Yazhe Wang, Xudong Sun, Guowen Liu, Jihong Dong
Rok vydání: 2019
Předmět:
medicine.medical_specialty
Very low-density lipoprotein
040301 veterinary sciences
Cattle Diseases
Fatty Acids
Nonesterified

Lipoproteins
VLDL

Perilipin-5
0403 veterinary science
Mice
Apolipoproteins E
NEFA
Lipid droplet
Internal medicine
Genetics
medicine
Animals
Diacylglycerol O-Acyltransferase
Triglycerides
chemistry.chemical_classification
3-Hydroxybutyric Acid
biology
Fatty Acids
Fatty liver
0402 animal and dairy science
Fatty acid
Lipid Droplets
04 agricultural and veterinary sciences
medicine.disease
Lipids
040201 dairy & animal science
Fatty Liver
Fatty acid synthase
Endocrinology
Liver
chemistry
Apolipoprotein B-100
biology.protein
Perilipin
Cattle
Female
lipids (amino acids
peptides
and proteins)

Animal Science and Zoology
Steatosis
Carrier Proteins
Sterol Regulatory Element Binding Protein 1
Food Science
Zdroj: Journal of Dairy Science. 102:833-845
ISSN: 0022-0302
DOI: 10.3168/jds.2018-15208
Popis: Fatty liver is a common metabolic disorder in dairy cows during the transition period. Perilipin 5 (PLIN5), a lipid droplet coat protein, plays important roles in the development of hepatic steatosis in mice and humans. Whether PLIN5 plays a role in the development of fatty liver in dairy cows is unknown. An in vivo study consisting of 10 healthy and 10 cows with fatty liver was performed to harvest liver tissue and blood samples. In addition, hepatocytes isolated from calves were infected with PLIN5 overexpression adenovirus for 48 h; treated with 0, 0.6, 1.2, or 2.4 mM nonesterified fatty acids (NEFA) for 24 h; or infected with PLIN5 silencing adenovirus for 48 h and then treated with 1.2 mM NEFA for 24 h. Serum concentrations of NEFA and β-hydroxybutyrate were greater in cows with fatty liver. Milk production and plasma glucose concentrations were lower in cows with fatty liver. The results revealed that PLIN5 is highly expressed in steatotic liver and localized to lipid droplets. The abundance of fatty acid and triacylglycerol (TAG) synthesis-related proteins including sterol regulatory element binding protein-1c, fatty acid synthase, acetyl-coA carboxylase 1, diacylglycerol acyltransferase 1, and diacylglycerol acyltransferase 2 was greater in the liver of cows with fatty liver. In contrast, the abundance of microsomal triglyceride transfer protein (MTP), apolipoprotein B100, and apolipoprotein E was lower in the liver of cows with fatty liver. Consequently, cows with fatty liver exhibited severe hepatic TAG accumulation and lower blood concentration of very low density lipoprotein apolipoprotein B (VLDL-ApoB). Overexpression of PLIN5 and exogenous NEFA in cultured hepatocytes increased the abundance of sterol regulatory element binding protein-1, fatty acid synthase, acetyl-coA carboxylase 1, diacylglycerol acyltransferase 1, and diacylglycerol acyltransferase 2 but decreased the abundance of microsomal triglyceride transfer protein, apolipoprotein B100, and apolipoprotein E, which promoted TAG synthesis and inhibited VLDL-ApoB assembly, inducing lipid accumulation. Importantly, knockdown of PLIN5 attenuated the upregulation of TAG synthesis and downregulation of VLDL-ApoB assembly induced by NEFA. Overall, these data suggest that NEFA activate PLIN5, leading to TAG accumulation and inhibition of VLDL assembly. As such, these mechanisms explain in part the development of hepatic steatosis in dairy cows.
Databáze: OpenAIRE